Flavonoids have a variety of physiological activities including anti-allergic actions. In the in vivo models, flavonoids show relaxant activity on guinea pig trachea, 1) and reduction of IgE-mediated cutaneous reactions in mice.
These anti-allergic actions are caused, at least in part, by inhibition of the mast cell activation.
2) Antigen-induced degranulation of RBL-2H3 cells 3) and of rat peritoneal mast cells 4) were reported to be inhibited by flavonoids. In addition to rodent mast cells, flavonoids also inhibited the activation of human cultured mast cells (HCMC), 5) which have been well-established for pharmacological studies. 6 ) Kimata et al. showed that luteolin, baicalein and quercetin inhibited the IgE-mediated release of histamine, leukotrienes (LTs) and granulocyte macrophage colony stimulating factor (GM-CSF) from HCMC and that these effects were due, at least in part, to the inhibition of the intracellular activation of protein kinase C (PKC). 5) In this report, these flavonoids were more potent in efficacy on the IgE-mediated degranulation than the A23187-induced degranulation. 5) Further, luteolin, baicalein and quercetin at 100 mM strongly inhibited histamine release from HCMC (90, 55 and 90%, respectively), but had a weak effect on PKC enzymatic activation (45, 15 and 40% inhibition, respectively). 5) These results suggested that another target molecule for flavonoids, besides PKC, existed in human mast cells, possibly further up-stream in the signal transduction pathway.
The activation of protein tyrosine kinase is an essential event in intracellular signal transduction from immune receptors, including T and B cell antigen receptors, high affinity IgE receptor (FceRI), and widely distributed IgG receptors. Spleen tyrosine kinase, p72 syk (Syk) was first isolated and characterized by Zioncheck et al. 7) and is known to be associated with FceRI and thus involved in the signaling pathway after cross-linking of this receptor by antigen in mast cells and basophils. 8) Indeed, Syk deficient RBL-2H3 cells showed no induction of degranulation, lipid mediator release or cytokine production after IgE stimulation. 8) Moreover, our recent studies suggested that a selective Syk kinase inhibitor BAY61-3606 blocked IgE-mediated release of histamine, tryptase, prostaglandin D 2 , cysteinyl leukotrienes and granulocyte macrophage colony stimulating factor from human cultured mast cells, in addition to inhibiting antigen-induced airway inflammation in rat. 9) These results implied that Syk is localized in the initial stage of the FceRI-mediated events in mast cells and basophils, and has an essential role in the signaling cascade.
To develop anti-allergic drugs modulating Syk activity, Syk kinase activation assay was established by our group, 10) using amino acid peptide corresponding to the activation loop domain of human Syk. 11) We then picked out 10 flavonoids classified into 4 series and examined their effects on the Syk kinase activity and in the HCMC degranulation assay. Moreover, we examined the relationship of the flavonoid-induced inhibition between the two assays. Some flavonoids are known to have low lipophilicity making it difficult for them to penetrate into the cells. Therefore, calculated logP (ClogP) 12, 13) was used to predict the lipophilicity of the flavonoids and the intrinsic cellular inhibitory effect was estimated by taking that value into account.
MATERIALS AND METHODS
Agents Luteolin (Ͻ90% pure) (Wako, Osaka, Japan); Apigenin (approx. 95% pure), Quercetin (Ͻ98% pure), Fisetin (Ͼ99% pure), Myricetin (approx. 85% pure), Morin (approx. 91% pure), Naringenin (approx. 95% pure), Hesperetin (Ͼ95% pure), Genistein (Ͼ98% pure) and Daidzein (Ͼ98% pure) (Sigma-Aldrich, St. Louis, MO, U.S.A.), were dissolved in dimethyl sulfoxide (DMSO) as 100 mM dilutions and stored. In our preliminary experiments, DMSO at the concentrations used in the present study (final 0.1%) had no effect on the activity of Syk or the mediator release from To 
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HCMC.
Syk Kinase Assay A Syk kinase assay was established by our group. 10) Briefly, glutathione S-transferase-tagged recombinant human Syk 14) was expressed in Sf-21 cells and purified with a glutathione affinity column. Biotinylated 30 amino acid-peptide (KISDFGLSKALRADENYYKAQTHG-KWPVKW) corresponding to the activation loop domain 11) of human Syk (biot-AL) was synthesized by Peptide Ins. (Osaka). 3.2 ng of GST-human Syk and 0.5 mg (3 mM) of biot-AL were mixed with 30 mM ATP in the presence of test compounds in the assay buffer (50 mM Tris-HCl (pH 8.0), 10 mM MgCl 2 , 0.1 mM Na 3 VO 4 , 0.1% BSA, 1 mM DTT) for 1 h at room temperature. After termination of the reaction by the addition of termination buffer (50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 500 mM NaCl, 0.1% BSA), biot-AL was trapped on the streptavidin coated plate. After washing with 0.05% Tween-20 containing TBS buffer (50 mM Tris-HCl (pH 8.0), 138 mM NaCl, 2.7 mM KCl), phosphotyrosine in biot-AL was detected by europium-labeled anti-phosphotyrosine mAb (4G10) using a multi-label counter ARVO (Wallac Oy, Finland) at 340 nm for excitation and 615 nm for emission. From Lineweaver-Burk plot analysis, apparent K m values for AL and ATP in this assay were calculated as 550 mM and 76 mM, respectively. The IC 50 value of nonspecific tyrosine kinase inhibitor staurosporine (Wako) 15) in this assay was 92 pM.
Mast Cell Culture Cultured mast cells were obtained from human umbilical cord blood cells according to the method described previously with some modification. 16) To describe in brief, mononuclear cells were separated from heparinized umbilical cord blood by lymphocyte separation medium (ICN Biomedicals Inc., Aurora, OH, U.S.A.) gradient. CD34 ϩ cells were purified by a CD34 ϩ progenitor cell isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany) and a magnetic cell sorting system (MACS; Miltenyi Biotec). Purified cells were cultured in the a-minimum essential medium (a-MEM; GIBCO-BRL Lab., Grand Island, NY, U.S.A.) containing 15% of fetal bovine serum (Filtron Pty, Ltd., Brooklyn, Australia) in the presence of 80 ng/ml of human recombinant stem cell factor (SCF, provided in part by Kirin Brewery, Maebashi, Japan, and the balance purchased from Peprotech, Rocky Hill, NJ, U.S.A.) and 50 ng/ml of human recombinant interleukin (IL)-6 (Kirin and Peprotech). The purity of mast cells was determined by immunocytochemical staining for tryptase and chymase as described previously. 6, 16) Cells were nearly 100% positive for tryptase and 14% positive for chymase, which were a mature form as previously described. 6, 16) Tryptase Release Assay HCMCs were sensitized with 1 mg/ml of human myeloma IgE (Chemicon Int. Inc., Temecula, CA, U.S.A.) at 37°C overnight. Cells were resuspended at 1ϫ10
5 cells/ml in Tyrode's solution containing 1 mM CaCl 2 , 0.6 mM MgCl 2 , 0.1% BSA (Sigma) at pH 7.4 and were treated with flavonoids for 10 min prior to challenging with anti-human IgE (DAKO, A/S, Denmark) at 4 mg/ml for 30 min. Supernatants were collected and incubated with BocAla-Gly-Pro-Arg peptide ligand (final 50 mM) at 37°C for 90 min. Fluorescence of 355-460 nm was measured by a fluorometer. The flavonoids themselves used in this study had no effect on tryptase enzymatic activity. The IC 50 value of the mast cell stabilizer, DSCG, 6) in this assay was 1 mM. Calculated logP (ClogP) Calculation The ClogP program implemented in SYBYL software (Tripos Inc.) was used to calculate ClogP values for the compounds.
12) The computationally obtained ClogP values were then used to estimate the cell permeability of the compounds.
Statistical Analysis The statistical difference between the flavonoid-treated response and the non-treated response was determined using Student's t-test for paired data. Fig. 1) were tested for Syk kinase activity and mast cell degranulation. As shown in Fig. 2 , concentration-dependent inhibition of Syk kinase activity was observed after treatment with flavones (luteolin and apigenin, (A)) and flavonols (quercetin, fisetin, myricetin and morin, (B)), but not with isoflavones (genistein and daistein, (D)). Flavanones (naringenin and hesperetin) showed weak but significant inhibition at highest concentration ( 
RESULTS
Four classes of flavonoids (shown in
Fig. 3. Effects of Flavonoids on the Degranulation of Human Mast Cells
Flavonoids, flavones (A), flavonols (B), flavanones (C) and isoflavones (D) were added to each of the assays as described in Materials and Methods. The mean value for spontaneous tryptase release was 4.5Ϯ1.0% of total cellular content which was determined by treatment with 1% triton X-100. IgE-mediated control tryptase release was 22.5Ϯ4.1% of total content. Data represents meanϮS.E.M. of 3 independent experiments. Significant difference between the flavonoid-treated response and the non-treated response: * Ͻ0.05. 2C). The order of potency expressed as IC 50 values for flavones and flavonols was apigeninϾmyricetinϾluteolinϾ fisetinϾquercetinϾmorin (Table 1) . Comparable to the Syk kinase assay, the degranulation of the HCMC was inhibited by flavones (Fig. 3A) and flavonols (Fig. 3B) , somewhat inhibited by flavanones at high concentrations (Fig. 3C) , but not by isoflavones (Fig. 3D) . The order of potency in IC 50 values for flavones and flavonols in the HCMC degranulation assay was apigeninϾluteolinϾfisetinϾquercetinϾmyricetinϾ morin (Table 1) . Interestingly myricetin exhibited strong inhibitory activity in the Syk kinase assay (IC 50 ϭ6.4 mM), but was merely a weak inhibitor in the HCMC degranulation assay (IC 50 ϭ54 mM). As can be seen in Table 1 , myricetin had the lowest lipophilicity indicated by the ClogP value. Due to the lower ClogP value signifying difficulty in cell membrane permeability, myricetin appeared to be strong in potency in the kinase assay but weak in potency in the cellular assay. Other flavonoids were expected to display similar poor lipophilicity and permeability, therefore the lipophilicities of all flavonoids were predicted by calculating the ClogP value for each of the compounds (Table 1) . Negative logarithm values for the IC 50 in Syk kinase (pSyk) and HCMC degranulation (pHCMC) are also shown in Table1. When we examined possible relationships between the inhibition of the pSyk and pHCMC by flavones and flavonols, no clear correlation was observed (Fig. 4A) . Actually, a regression analysis gave an equation of pHCMC (calculation 1)ϭ0.79 pSyk ϩ0.92, which only yielded a poor correlation coefficient (r 2 ϭ0.16, Table 1 ). As a matter of course, there was no clear relationship between pHCMC (observed) and pHCMC (calculation 1) (Fig. 4B) . However, when the lipophilicity for each of the compounds (ClogP) was taken into account as a measure of the membrane permeability, a multiple regression analysis gave a much improved correlation (r 2 ϭ0.89) with an equation of pHCMC (calculation 2)ϭ0.36 pSykϩ0.62 ClogPϩ2.39 (Table 1, Fig. 5 ). These results suggest that by taking into account ClogP in addition to the efficacy on Syk, The means of each value are shown in Table 1 . Table 1. the observed efficacy on cells could be reproduced. The positive contribution (0.62) of ClogP to the cellular activity in the equation is quite reasonable, as it indicates that the higher lipophilicity (cell membrane permeability) of the compounds would enhance the cellular activity.
DISCUSSION
FceRI-crosslinking in mast cells and basophils activates receptor-associated protein-tyrosine kinases, such as Lyn and Syk. Flavonoids are known to inhibit the activities of several kinases: PKC, phosphatidylinositol 3-kinase (PI3k) and protein kinase A. 17, 18) Our previous study also demonstrated that flavonoids inhibited the IgE-dependent PKC activation in the cellular system. 5) However, no report has examined the effect of flavonoids on the activation of Syk tyrosine kinase, which is an essential molecule in initiation of FceRI mediated signaling. 8) In the present study, the inhibitory effect of four classes of flavonoids on the Syk activation and HCMC degranulation (tryptase release) was highlighted. Among them, flavones and flavonols were found to be potent inhibitors of Syk and mast cell degranulation. In the previous study, we established a Syk dependent cellular assay using human monocyte-like lymphoma U937 cells, 19) and we confirmed that luteolin inhibited FcgRI-mediated Syk autophosphorylation, which was detected with anti-phosphorylated Syk Ab after the lysates of cells were immunoprecipitated with antiSyk (unpublished data). Flavonoids, therefore, seem to inhibit Syk activity in cells at the autophosphorylation level. They might bind to the ATP binding region of Syk the same as PKC and PI3k, 20) and result in inhibition of kinase activity. Basically, flavonoid has broad inhibitory effects on several tyrosine kinases. However, the inhibitory potency of flavonoids in Syk kinase assay (apigeninϾmyricetinϾlute-olinϾquercetin) was different from that of PKC (luteolinϾ quercetinϾmyricetinϾapigenin) and PI3k (myricetinϾ quercetinϾluteolinϾapigenin) described in a previous report. 18) These results suggested that flavonoids have some selectivity against tyrosine kinases. Moreover, Syk is located at almost the supreme site in FceRI-signaling, therefore, Syk inhibition by flavonoids could be the most essential effect in IgE-mediated mast cell stimulation.
The structure-activity relationships of flavonoids on Syk activity and the HCMC degranulation were of interest in the present study. Ten flavonoids classified into 4 series were selected. Among them, flavones and flavonols showed potent inhibition of Syk kinase activity and HCMC degranulation. In comparison, pyrine ring C2-C3 bond saturation (flavanones) presented only weak inhibition at higher concentrations, and C3 phenyl groups (isoflavones) were without effect. These results suggested that the potency of flavonoids was characterized by a 7-hydroxy benzopyrone with a 4-carbonyl and 3-or 5-hydroxy 2-phenyl ring. In our previous report, baicalein (Fig. 1) showed 27.9Ϯ6.6% inhibition (nϭ3) at 30 mM in HCMC degranulation. 5) And in the present enzyme study, it showed 23.1Ϯ5.6% inhibition (nϭ4) at 30 mM in Syk kinase activity. The ClogP value of baicalein was 3.0 which meant a good lipophilicity and easy permeability into cells. Therefore, the results that the efficacy of baicalein in both enzyme assay and cellular assay was of almost the same extent indicated that its target molecule might be Syk. Although baicalein has a flavone structure, it had no significant effect in either assay. Only baicalein lacked the hydroxyl group in the 4Ј position in the present study (Fig. 1) , suggesting that its presence might be important in inhibiting Syk activation.
Myricetin showed a good potency in the Syk kinase assay (IC 50 ϭ6.4 mM), but meager inhibition in the HCMC degranulation assay (IC 50 ϭ54 mM). The difference between the biochemical assay and cellular assay may be attributed to the lower levels of lipophilicity of myricetin as indicated by the ClogP value. Computational approaches to estimate lipophilicity and permeability are considered to be of use for drug discovery and development, and ClogP has been widely used to estimate the lipophilicity of organic compounds. The usefulness of ClogP in studying biological membrane transportation phenomena such as cell membrane permeability 12, 13) has been reported, hwevere, no report has shown the calculation formula including ClogP in phamacological studies for mast cell degranulation. In the present study, we were able to recognize a significant correlation between inhibition of Syk activity and that of HCMC degranulation by flavonoids only when compound lipophilicity, expressed by ClogP, was taken into consideration during the data analysis.
In conclusion, flavonoids, especially flavones and flavonols inhibit Syk tyrosine kinase, and their inhibitory effects on human mast cell function are mediated, at least in part, via the suppression of intracellular enzymatic activity of Syk in addition to PKC.
